10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology
PLEASANTON, Calif., Feb. 5, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a series of new products and technology demonstrations that will be presented at the 2024 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Orlando, Florida.
Related news for (TXG)
- Breaking News: MoBot’s Latest Update as of 09/22/25 03:00 PM
- CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
- 10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
- 10x Genomics to Acquire Scale Biosciences
- 10x Genomics Reports Second Quarter 2025 Financial Results